Equities

Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Ltd

Actions
  • Price (INR)2,310.00
  • Today's Change-29.95 / -1.28%
  • Shares traded1.15k
  • 1 Year change+69.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 05:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue2,125450247
OPERATING EXPENSES
Cost of revenue total1,643214123
Selling, general and admin. expenses, total20313084
Depreciation/amortization8.964.771.55
Unusual expense(income)--0.170
Other operating expenses, total0.170.020.04
Total operating expense1,856350208
Operating income26910139
Other, net8.904.541.80
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes31811445
Provision for income taxes592912
Net income after taxes2608534
Minority interest(44)----
Net income before extra. Items2158534
Total extraordinary items------
Net income2158534
Inc.avail. to common excl. extra. Items2158534
Inc.avail. to common incl. extra. Items2158534
EPS RECONCILIATION
Basic/primary weighted average shares5.674.095.89
Basic/primary eps excl. extra items38215.75
Basic/primary eps incl. extra items38215.75
Dilution adjustment------
Diluted weighted average shares5.674.095.89
Diluted eps excl. extra items38215.75
Diluted eps incl. extra items38215.75
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.500.500
Gross dividend - common stock5.8900
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental3.130.810.22
SUPPLEMENTAL INCOME
Depreciation, supplemental8.734.641.55
Total special items(15)0.170
NORMALISED INCOME
Normalized income before taxes30311445
Effect of special items on income taxes(2.78)0.040
Income tax excluding impact of special items562912
Normalized income after tax2478534
Normalized income avail. to common2038534
Basic normalized EPS36215.75
Diluted normalized EPS36215.75
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.